Fingerprint
Dive into the research topics of 'Combined epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitor and chemotherapy in non-small-cell lung cancer: Chemo-refractoriness of cells harboring sensitizing-EGFR mutations in the presence of gefitinib'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically